Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Notified -
Globe Newswire28-08-2025, 19:30
MGA Entertainment Initiates Merger with Zapf Creation AG 9-10-2023, 14:02